A Double-blind, Randomized, Multicenter, Noninferiority, Phase II Repeat Dose Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

Trial Profile

A Double-blind, Randomized, Multicenter, Noninferiority, Phase II Repeat Dose Study of CG100649 Versus Celecoxib in Osteoarthritis Patients

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Oct 2012

At a glance

  • Drugs Polmacoxib (Primary) ; Celecoxib
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Apr 2012 Status changed from recruiting to active, no longer recruiting, accorging to a CrystalGenomics media release.
    • 19 Apr 2012 Secondary endpoint 'Analgesic-consumption' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top